MedPath

Combination of reduced doses of naltrexone and cranial electrical stimulation in fibromyalgia: randomized clinical trial, blind, controlled with placebo

Not Applicable
Recruiting
Conditions
fibromyalgia
M79.7
C05.651.324
Registration Number
RBR-7hk8n3
Lead Sponsor
niversidade La Salle
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Provide an informed consent to participate on the study; women with age between 18 and 65 years; medical diagnoses of fibromyalgia according to the American College of Rheumatology criterion (2010); know how to read and write; pain evaluated as bigger than six at the last 3 months on the Visual Analogic Scale; treatment of chronic use stable on the last 3 months;

Exclusion Criteria

Be using opioid drugs; pregnancy or non-use of contraceptive method; history of alcohol or drugs abuse on the last 6 months; historic of neurologic pathology; history of cardiac arrhythmia and use of drugs that change the vascular answer (adrenergic blockers, vasodilators); history of cranial traumatism moderated or severe; history of neurosurgery; systemic decompensated disease, and chronic inflammatory disease (Lupus, rheumatoid arthritis, Sjogren Syndrome, Reiter Syndrome); history of hypothyroidism non compensated; personal history of cancer, passed or in treatment.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath